Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,791 | 94,613 | 129,481 | 222,479 | 74,485 |
| Marketable Securities | 392,646 | 390,323 | 335,041 | 203,806 | 85,723 |
| Receivables | 73,673 | 82,195 | 52,104 | 45,031 | 53,962 |
| Inventories | 66,816 | 63,721 | 70,644 | 62,263 | 60,469 |
| TOTAL | $661,696 | $637,235 | $592,293 | $539,679 | $280,873 |
| Non-Current Assets | |||||
| PPE Net | 50,445 | 50,022 | 49,320 | 44,385 | 37,626 |
| Other Non-Current Assets | 42,132 | 29,158 | 31,375 | 32,175 | 24,828 |
| TOTAL | $92,577 | $79,180 | $80,695 | $76,560 | $62,454 |
| Total Assets | $754,273 | $716,415 | $672,988 | $616,239 | $343,327 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 28,184 | 17,805 | 20,499 | 16,371 | 21,783 |
| Accrued Expenses | 5,058 | 4,783 | 6,349 | 4,563 | 5,896 |
| Other current liabilities | 21,341 | 31,602 | 33,557 | 53,694 | 37,212 |
| TOTAL | $103,410 | $103,852 | $105,506 | $114,307 | $99,647 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 195,344 | N/A |
| Deferred Revenues | 6,670 | 6,082 | 5,210 | 4,642 | 4,377 |
| Other Non-Current Liabilities | 337,449 | 246,258 | 240,938 | 38,884 | 36,504 |
| TOTAL | $337,449 | $246,258 | $240,938 | $234,228 | $36,504 |
| Total Liabilities | $440,859 | $350,110 | $346,444 | $348,535 | $136,151 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,638 | 62,505 | 62,195 | 60,906 | 60,103 |
| Common Shares | 63 | 62 | 62 | 61 | 60 |
| Retained earnings | -655,205 | -659,210 | -676,210 | -666,802 | -639,695 |
| Other shareholders' equity | 106 | 220 | 190 | 43 | -245 |
| TOTAL | $313,414 | $366,305 | $326,544 | $267,704 | $207,176 |
| Total Liabilities And Equity | $754,273 | $716,415 | $672,988 | $616,239 | $343,327 |